Form 4 for TMO Thermo Fisher Scientific
Accepted 2023-08-31 00:00:00 ET · period of report 2023-08-30 · accession 0001127602-23-023484 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-08-31 | 2023-08-30 | TMO | Pettiti Gianluca | EVP | S - Sale+OE | $557.77 | -3,000 | 17.6K | -15% | -$1.67M |
| D | 2023-08-31 | 2023-08-30 | TMO | Pettiti Gianluca | EVP | M - OptEx | $253.99 | +3,000 | 20.6K | +17% | +$762.0K |
| D | 2023-08-31 | 2023-08-30 | TMO | Pettiti Gianluca | EVP | M - OptEx | $0.00 | -3,000 | 725 | -81% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-30 | S | D | 3,000 | $557.77 | 17,555.67 | D | — | — | |
| 2 | Common | Common Stock | 2023-08-30 | M | A | 3,000 | $253.99 | 20,555.67 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2023-08-30 | M | D | 3,000 | $0.00 | 725 | D | $253.99 · — to 2026-02-26 | 3,000 Common Stock | (F2) The option vested in four equal installments on February 26, 2020, 2021, 2022 and 2023. |